A first-of-its-kind study has determined that although African-American women may have lower levels of the biomarker used to measure Vitamin D levels-25-hydroxyvitamin D or 25OHD-older African-American women and Caucasian women require the same amount of vitamin D supplementation.
A first-of-its-kind study has determined that although African-American women may have lower levels of the biomarker used to measure Vitamin D levels-25-hydroxyvitamin D or 25OHD-older African-American women and Caucasian women require the same amount of vitamin D supplementation.
The researchers set out to determine why 25OHD is lower in women with darker skin color. No study had determined if this is due to lower skin production, lower absorption, or different metabolism of vitamin D.
The researchers at Creighton University School of Medicine in Omaha, Nebraska, and Indiana University School of Medicine in Indianapolis, Indiana, examined vitamin D doses in 110 African-American women between the ages of 57 and 90. They claim that this was the first randomized controlled dose response study conducted in this population with a goal of setting a recommended dietary allowance (RDA).
Study participants were randomly assigned to placebo or vitamin D3 dosages of 400, 800, 1600, 2400, 3200, 4000, or 4800 IU daily; calcium supplements were given to maintain total calcium intake of 1200 mg/d to 1400 mg/d. At 12 months the researchers measured the participants’ serum 25OHD and serum PTH levels.
They found that vitamin D3 supplementation increased serum 25OHD in the African-American women just as it did in the Caucasian women. The researchers concluded that because absorption and metabolism of oral vitamin D was similar in the 2 groups, lower levels of serum 25OHD in African-American women must be due to lower production of vitamin D in their skin.
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More